A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.
Andersen CL, McMullin MF, Ejerblad E, Zweegman S, Harrison C, Fernandes S, Bareford D, Knapper S, Samuelsson J, Löfvenberg E, Linder O, Andreasson B, Ahlstrand E, Jensen MK, Bjerrum OW, Vestergaard H, Larsen H, Klausen TW, Mourits-Andersen T, Hasselbalch HC.
Andersen CL, et al. Among authors: mcmullin mf.
Br J Haematol. 2013 Aug;162(4):498-508. doi: 10.1111/bjh.12416. Epub 2013 Jun 11.
Br J Haematol. 2013.
PMID: 23758082
Free article.
Clinical Trial.